Forbes China interviewed Zensun’s CEO Dr. Mingdong Zhou and reviewed the history that Mr. Zhou discovered the ‘first in class’ anti-heart failure drug rhNRG-1.

For original paper, please click http://www.forbeschina.com/review/201206/0017257.shtml